ALO-001

N/A

Report date: 2024/05/08 17:25:47
NME

Base Information

Drug NameALO-001
Drug Alias NameALO-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDeubiquitinating enzymes inhibitors
TargetsDeubiquitinating enzymes
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlleo Labs
China Registration ClassN/A

Develop Information

Active CompaniesAlleo Labs
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A